223 related articles for article (PubMed ID: 37775331)
1. Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations.
Chothe PP; Arya V; Prasad B; Ramsden D; Taskar K
Drug Metab Dispos; 2023 Dec; 51(12):1547-1550. PubMed ID: 37775331
[TBL] [Abstract][Full Text] [Related]
2. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
Sharma S; Suresh Ahire D; Prasad B
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
[TBL] [Abstract][Full Text] [Related]
3.
Singh DK; Ahire D; Davydov DR; Prasad B
Drug Metab Dispos; 2024 Apr; ():. PubMed ID: 38641346
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Analysis of Gene Expression of Xenobiotic and Endogenous Metabolizing Enzymes and Transporters in Rat Multiple Organs.
Hou W; Zhu S; Shang J; Li B; Zheng Y; Yu Y; Shi L
Curr Pharm Biotechnol; 2018; 19(3):240-249. PubMed ID: 29793406
[TBL] [Abstract][Full Text] [Related]
5. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters.
Li J; Zhu HJ
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545386
[TBL] [Abstract][Full Text] [Related]
6. A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.
Ladumor MK; Thakur A; Sharma S; Rachapally A; Mishra S; Bobe P; Rao VK; Pammi P; Kangne H; Levi D; Balhara A; Ghandikota S; Joshi A; Nautiyal V; Prasad B; Singh S
Sci Rep; 2019 Jul; 9(1):9709. PubMed ID: 31273226
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.
Chu X; Prasad B; Neuhoff S; Yoshida K; Leeder JS; Mukherjee D; Taskar K; Varma MVS; Zhang X; Yang X; Galetin A
Clin Pharmacol Ther; 2022 Sep; 112(3):501-526. PubMed ID: 35561140
[TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS.
Ahire DS; Basit A; Karasu M; Prasad B
J Pharm Sci; 2021 Jul; 110(7):2833-2840. PubMed ID: 33785352
[TBL] [Abstract][Full Text] [Related]
9.
Amaeze O; Isoherranen N; Shum S
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38811157
[TBL] [Abstract][Full Text] [Related]
10. Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.
Alrubia S; Mao J; Chen Y; Barber J; Rostami-Hodjegan A
Clin Pharmacokinet; 2022 Oct; 61(10):1365-1392. PubMed ID: 36056298
[TBL] [Abstract][Full Text] [Related]
11. Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions.
Taskar KS; Harada I; Alluri RV
Curr Drug Metab; 2021; 22(7):523-531. PubMed ID: 33397250
[TBL] [Abstract][Full Text] [Related]
12. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
[No Abstract] [Full Text] [Related]
13. Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling.
Sharma S; Singh DK; Mettu VS; Yue G; Ahire D; Basit A; Heyward S; Prasad B
Mol Pharm; 2023 Mar; 20(3):1737-1749. PubMed ID: 36791335
[TBL] [Abstract][Full Text] [Related]
14. Sex and the Kidney Drug-Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
Thakur A; Yue G; Ahire D; Mettu VS; Al Maghribi A; Ford K; Peixoto L; Leeder JS; Prasad B
Clin Pharmacol Ther; 2024 Jul; 116(1):235-246. PubMed ID: 38711199
[TBL] [Abstract][Full Text] [Related]
15. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?
Isoherranen N; Thummel KE
Drug Metab Dispos; 2013 Feb; 41(2):256-62. PubMed ID: 23328895
[TBL] [Abstract][Full Text] [Related]
16. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
Rodrigues AD; Rowland A
J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
[TBL] [Abstract][Full Text] [Related]
17. Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy.
Han LW; Wang L; Shi Y; Dempsey JL; Pershutkina OV; Dutta M; Bammler TK; Cui JY; Mao Q
Drug Metab Dispos; 2020 Aug; 48(8):708-722. PubMed ID: 32499338
[TBL] [Abstract][Full Text] [Related]
18. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.
Stanke-Labesque F; Gautier-Veyret E; Chhun S; Guilhaumou R;
Pharmacol Ther; 2020 Nov; 215():107627. PubMed ID: 32659304
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
